Staff editor

Biocodex plans €15m manufacturing investment under MRM Health partnership

The non-exclusive agreement will support MRM Health’s live biotherapeutic pipeline, with commercial-scale manufacturing targeted from 2030.

ADM and Asahi target functional beverages with expanded postbiotic deal

The broader CP2305 licensing agreement opens new commercial opportunities, while research on acute stress responses adds to the ingredient’s scientific positioning.

ARFID in IBS Patients: why early recognition is essential for effective management

Chloé Melchior, from Rouen University Hospital, France, explains why gastroenterologists and general practitioners should be able to recognize ARFID and adapt their therapeutic strategies accordingly.

Beyond the colon: rethinking the small intestine’s role in IBS

Tim Vanuytsel, Associate Professor and gastroenterologist at UZ Leuven, explores why research should look beyond the colon, particularly given the early onset of symptoms after food intake in many patients.

ProDigest celebrates 18 years of scientific innovation with a new brand identity

On September 24th, ProDigest celebrated its 18th birthday with a brand-new look to match this milestone.

From food waste to value: fermentation for nutraceuticals & functional ingredients

Fermentation techniques offer a powerful biotransformation pathway to valorise these materials into high-value nutraceuticals and functional ingredients.

IBS, sex differences and the microbiome: exploring the estrogen connection

UCLA’s Lisa Chang explores differences in bowel habits, intestinal transit and pain, discussing how these factors relate to microbial composition and function. 

Mapping bloating: what symptom location may reveal about IBS and functional dyspepsia

Lukas Michaja Balsiger, KU Leuven, discusses findings linking upper abdominal bloating more closely to functional dyspepsia and lower abdominal bloating to irritable bowel syndrome (IBS). 

Colon-targeted vitamin B2: how delivery technology could reshape the biotics market

Humiome® B2 uses a patented coating technology intended to transport riboflavin through the upper gastrointestinal tract and release most of it in the ileal-colonic region.

Auto-brewery syndrome: when the gut microbiota produces alcohol without drinking

William Fusco, Policlinico Gemelli, discusses the gut fermentation syndrome, a rare condition arising when ethanol-producing bacteria or fungi in the gut generate excessive amounts of alcohol from dietary carbohydrates.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.